Literature DB >> 8551943

Phase-shift of polysaccharide capsule expression in group B streptococci, type III.

M Sellin1, S Håkansson, M Norgren.   

Abstract

The type-specific polysaccharide capsule is an important virulence determinant in group B streptococci (GBS). The previously described inverse relationship between the buoyant density of a GBS-isolate and the capsular thickness was used to assess the frequencies of polysaccharide capsular phase-shift in clinical GBS, type III strains. Shift from intermediate density (ID) of parental strains, to high density (HD), i.e. shift from intermediate capsule thickness to poor encapsulation, was found to range from 1.2 x 10(-3) to 4.8 x 10(-6). Shift from ID to low density (LD), i.e. shift to abundant encapsulation, ranged from 1.9 x 10(-4) to 1.1 x 10(-7). Shifts were reversible in all cases, either directly (HD-->LD or vice versa) or through intermediate forms. Reversion frequencies were in some isolates as high as 10(-1). Phase-shift frequencies differed more than a thousand-fold between compared strains. Differences in phenotypic shift between strains were validated using flow cytometry. Possible modulation of capsule expression by changes in culture conditions was assessed. Variation of temperature, oxygen-tension, and presence of human serum did not affect capsule expression. However, growth at pH below 5.5 decreased the amount of capsule bound native type III polysaccharide, probably through phenotypic modification rather than genetic shift. IS861, an insertion sequence which has been proposed a regulatory function on the GBS capsule expression, was found in multiple copies in the isolates investigated. No differences in copy number or location of IS861 between the differently encapsulated phenotypes were found.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8551943     DOI: 10.1006/mpat.1995.0036

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  13 in total

1.  Differential expression of Vibrio vulnificus capsular polysaccharide.

Authors:  A C Wright; J L Powell; M K Tanner; L A Ensor; A B Karpas; J G Morris; M B Sztein
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

2.  Membrane topology and DNA-binding ability of the Streptococcal CpsA protein.

Authors:  Brett R Hanson; Beth A Lowe; Melody N Neely
Journal:  J Bacteriol       Date:  2010-11-19       Impact factor: 3.490

3.  Identification of a distinct, cryptic heparosan synthase from Pasteurella multocida types A, D, and F.

Authors:  Paul L Deangelis; Carissa L White
Journal:  J Bacteriol       Date:  2004-12       Impact factor: 3.490

4.  Acquisition of insertion sequences and the GBSi1 intron by Streptococcus agalactiae isolates correlates with the evolution of the species.

Authors:  Geneviève Héry-Arnaud; Guillaume Bruant; Philippe Lanotte; Stella Brun; Agnès Rosenau; Nathalie van der Mee-Marquet; Roland Quentin; Laurent Mereghetti
Journal:  J Bacteriol       Date:  2005-09       Impact factor: 3.490

5.  Identification and molecular characterization of a S. agalactiae strain lacking the capsular locus.

Authors:  R Creti; M Imperi; M Pataracchia; G Alfarone; S Recchia; L Baldassarri
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-05-26       Impact factor: 3.267

6.  Analysis of the polysaccharide capsule of the systemic pathogen Streptococcus iniae and its implications in virulence.

Authors:  Beth A Lowe; Jesse D Miller; Melody N Neely
Journal:  Infect Immun       Date:  2006-12-28       Impact factor: 3.441

7.  Large-scale screen highlights the importance of capsule for virulence in the zoonotic pathogen Streptococcus iniae.

Authors:  Jesse D Miller; Melody N Neely
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

8.  Genotyping of the capsule gene cluster (cps) in nontypeable group B streptococci reveals two major cps allelic variants of serotypes III and VII.

Authors:  M Sellin; C Olofsson; S Håkansson; M Norgren
Journal:  J Clin Microbiol       Date:  2000-09       Impact factor: 5.948

9.  Changes in availability of oxygen accentuate differences in capsular polysaccharide expression by phenotypic variants and clinical isolates of Streptococcus pneumoniae.

Authors:  J N Weiser; D Bae; H Epino; S B Gordon; M Kapoor; L A Zenewicz; M Shchepetov
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

10.  Uptake of Streptococcus pneumoniae by respiratory epithelial cells.

Authors:  U M Talbot; A W Paton; J C Paton
Journal:  Infect Immun       Date:  1996-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.